Patents by Inventor Sybille Mazurek

Sybille Mazurek has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • 1-BUTANE ACID DERIVATIVES, PHARMACEUTICAL COMPOSITIONS CONTAINING SAID DERIVATIVES AND THE USE THEREOF
    Publication number: 20100256230
    Abstract: The invention relates to new butane acid derivatives comprising a cyanide group, pharmaceutical compositions containing said butane acid derivatives and the use of said butane acid derivatives in the production of pharmaceutical compositions for treating various illnesses.
    Type: Application
    Filed: October 5, 2009
    Publication date: October 7, 2010
    Applicant: SCHEBO BIOTECH AG
    Inventors: Erich Eigenbrodt, Stefan Mullner, Sybille Mazurek, Hugo Fasold
  • USE OF SUGAR PHOSPHATES, SUGAR PHOSPHATE ANALOGS, AMINO ACIDS AND/OR AMINO ACID ANALOGS FOR MODULATING THE GLUCOLYSIS-ENZYME COMPLEX, THE MALATE ASPARATE SHUTTLE AND/OR THE TRANSAMINASES
    Publication number: 20090163591
    Abstract: The invention relates to methods for the treatment of tumors and/or for immune suppression and/or sepsis by modulating the association of the glycolysis enzyme complex/M2-PK and/or by inhibition of transaminases and/or separation of the binding of the malate dehydrogenase to p36 comprising administering a pharmaceutical composition comprising a substance selected from the group consisting of amino acids, amino acid analogs, sugar phosphates, sugar phosphate analogs, and mixtures of said substances.
    Type: Application
    Filed: December 16, 2008
    Publication date: June 25, 2009
    Inventors: Erich Eigenbrodt, Sybille Mazurek, Helmut Grimm
  • Compounds for the modulation of the glykolysis-enzyme-and/or of the transaminase-complex
    Publication number: 20070238781
    Abstract: The invention relates to compounds for the modulation of the glycolysis enzyme complex and of the transaminase complex, pharmaceutical compositions containing such compounds as well as uses of such compounds for preparing pharmaceutical compositions for treating various diseases.
    Type: Application
    Filed: May 26, 2007
    Publication date: October 11, 2007
    Inventors: Erich Eigenbrodt, Hans Scheefers, Sybille Mazurek
  • Compounds for the modulation of the glycolysis enzyme and/or transaminase complex
    Patent number: 7223784
    Abstract: The invention relates to compounds for the modulation of the glycolysis enzyme complex and of the transaminase complex, pharmaceutical compositions containing such compounds as well as uses of such compounds for preparing pharmaceutical compositions for treating various diseases.
    Type: Grant
    Filed: July 11, 2003
    Date of Patent: May 29, 2007
    Assignee: ScheBo® Biotech AG
    Inventors: Erich Eigenbrodt, Hans Scheefers, Sybille Mazurek
  • Use of sugar phosphates, sugar phosphate analog, amino acids, amino acid analogs for modulating transaminases and/or the association of p36/ malate dehydrogenase
    Publication number: 20050054584
    Abstract: The invention relates to the use of a substance being selected from the group consisting of “sugar phosphates, sugar phosphate analogs, amino acids, amino acid analogs, and mixtures of said substances” for producing a pharmaceutical composition for reducing weight and/or preventing delayed damage caused by diabetes mellitus by modulating the association p36/malate dehydrogenase and/or transaminases.
    Type: Application
    Filed: March 12, 2002
    Publication date: March 10, 2005
    Inventors: Erich Eigenbrodt, Sybille Mazurek, Stefan Mullner
  • 1-butane acid derivatives pharmaceutical compositions containing said derivatives and the use thereof
    Publication number: 20040266873
    Abstract: The invention relates to new butane acid derivatives comprising a cyanide group, pharmaceutical compositions containing said butane acid derivatives and the use of said butane acid derivatives in the production of pharmaceutical compositions for treating various illnesses.
    Type: Application
    Filed: August 9, 2004
    Publication date: December 30, 2004
    Inventors: Erich Eigenbrodt, Stefan Mullner, Sybille Mazurek, Hugo Fasold
  • Use of amino acids amino acid alogues, sugar phosphates and sugar phosphate analogues for treatment of tumors, treatment of sepsis and immunosuppression
    Publication number: 20040235755
    Abstract: The invention relates to methods for the treatment of tumors and/or for immune suppression and/or sepsis by modulating the association of the glycolysis enzyme complex/M2-PK and/or by inhibition of transaminases and/or separation of the binding of the malate dehydrogenase to p36 comprising administering a pharmaceutical composition comprising a substance selected from the group consisting of amino acids, amino acid analogs, sugar phosphates, sugar phosphate analogs, and mixtures of said substances.
    Type: Application
    Filed: June 4, 2004
    Publication date: November 25, 2004
    Inventors: Erich Eigenbrodt, Sybille Mazurek, Helmut Grimm
  • 1-butyric acid derivatives and the use thereof
    Publication number: 20040152772
    Abstract: Provided is a group of active substances capable of inhibiting the proliferation of cancer cells and inhibiting inflammation, as well as suppressing bodily defense reactions to control autoimmune diseases, transplant rejections, and acute and chronic inflammatory reactions.
    Type: Application
    Filed: March 15, 2004
    Publication date: August 5, 2004
    Inventors: Erich Eigenbrodt, Stefan Muellner, Sybille Mazurek, Hugo Fasold
  • Compounds for the modulation of the glycolysis enzyme and/or transaminase complex
    Publication number: 20040147587
    Abstract: The invention relates to compounds for the modulation of the glycolysis enzyme complex and of the transaminase complex, pharmaceutical compositions containing such compounds as well as uses of such compounds for preparing pharmaceutical compositions for treating various diseases.
    Type: Application
    Filed: July 11, 2003
    Publication date: July 29, 2004
    Applicant: ScheBo Biotech AG
    Inventors: Erich Eigenbrodt, Hans Scheefers, Sybille Mazurek